SCHEMBL6788322

SCHEMBL6788322

Cn1ncc2[nH]c3ccc(Cc4ccccc4N)cc3c(=O)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.37
MAPK1 P28482 2/20 0.33
MPO P05164 2/20 0.33
NPC1 O15118 2/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
BACE1 P56817 1/20 0.32
GABRA1 P14867 2/20 0.32
GABRB2 P47870 2/20 0.32
PRMT5 O14744 2/20 0.31
WDR77 Q9BQA1 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6782998 0.99 AR (0.36) ARMAPK1MPONPC1MEN1
SCHEMBL6791754 0.89 BPTF (0.35) MAPK1NPC1MEN1POLBKMT2A
Hydrochloric Acid SCHEMBL6782358 0.88 BPTF (0.35) MAPK1NPC1MEN1POLBKMT2A
SCHEMBL6785194 0.87 HTR2A (0.37) MAPK1PRMT5WDR77CTSVCTSL
SCHEMBL6786192 0.87 KEAP1 (0.36) MAPK1NPC1MEN1POLBKMT2A
SCHEMBL6784689 0.87 PRMT5 (0.37) ARMEN1POLBKMT2APRMT5
Hydrochloric Acid SCHEMBL6784268 0.86 HTR2A (0.36) MAPK1PRMT5WDR77CTSVCTSL
SCHEMBL6783054 0.86 MAPK1 (0.32) MAPK1NPC1MEN1POLBKMT2A
SCHEMBL6787085 0.85 GABRA1 (0.36) GABRA1GABRB2KDM4EALDH1A1LMNA
SCHEMBL6785795 0.85 GABRA1 (0.44) MAPK1POLBGABRA1GABRB2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG AR 3413/4885MAPK1 18/4885MPO 3703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.